N-Carbobenzyloxy-L-valinyl-ganciclovir

Basic Information

View in Editor

CAS Number

194154-40-0

Molecular Formula

C22H28N6O7

Molecular Weight

488.5 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Esters

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Amines

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

SMILES

View in Editor

CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)NC(=O)OCC3=CC=CC=C3

InChI

InChI=1S/C22H28N6O7/c1-13(2)16(25-22(32)34-9-14-6-4-3-5-7-14)20(31)33-10-15(8-29)35-12-28-11-24-17-18(28)26-21(23)27-19(17)30/h3-7,11,13,15-16,29H,8-10,12H2,1-2H3,(H,25,32)(H3,23,26,27,30)/t15?,16-/m0/s1

InChIKey

UMWCZUCRFYVVAW-LYKKTTPLSA-N

LogP

0.531000000000001

Topological Polar Surface Area

183.68 Å²

Hydrogen Bond Donor/Acceptor

5 / 13

Complexity

773

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

CBZ-Vaganciclovir
A813704
2-[(2-Amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl (2S)-2-(Benzyloxycarbonylamino)-3-methylbutanoate (N-(Benzyloxycarbonylamino)valganciclovir)
194154-40-0
CS-0141974
DTXSID80453676
N-Cbz-L-valinyl-ganciclovir
N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl Ester
SCHEMBL14125271
D83784
AKOS030241697
Valganciclovirhydrochloride impurity 30
[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoate
J-012574
AC-23937
L-Valine, N-[(phenylmethoxy)carbonyl]-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester
2-((2-Amino-6-oxo-3,6-dihydro-9H-purin-9-yl)methoxy)-3-hydroxypropyl ((benzyloxy)carbonyl)-L-valinate
VPY4357225
AKOS015896090
(2S)-3-hydroxy-2-((2-imino-6-oxo-2,3-dihydro-1H-purin-9(6H)-yl)methoxy)propyl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate
[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxy-propyl] 2-(benzyloxycarbonylamino)-3-methyl-butanoate;CBZ-Vaganciclovir
DS-19643
N-Carbobenzyloxy-L-valinyl-ganciclovir
N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl Ester;
Cbz-Valine ganciclovir
2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-3-hydroxy-1-propyl N-(benzyloxycarbonyl)-L-valinate
N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester
[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoate
2-(2-amino-1,6 dihydro-6-oxo-purine-9-yl)-methoxy-3 hydroxy-1-propyl-N-(benzyloxycarbonyl)-L-valinate
CBZ-protected mono-L-valyl ester of ganciclovir
CBZ-valganciclovir

MDL Number

MFCD13194862

FAQ

What regulatory guidelines apply to N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0)?

N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) falls under several regulatory guidelines. It should comply with the International Chemical Safety Card (ICSC) and the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). For European markets, it must adhere to REACH regulations. In the U.S., it is subject to FDA and EPA requirements.

Are there alternatives to N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) in synthesis?

Yes, alternatives to N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) include similar ganciclovir derivatives such as N,N-Diisopropyldiethylammonium ganciclovir and N-Carbobenzyloxy-L-valinyl-ganciclovir itself has isomers. Common alternative reagents include other protecting groups like benzyl or methyl groups.

What is the market or research trend for N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0)?

The market trend for N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) is driven by its use in antiviral research and development. Recent studies focus on its role in HIV and herpes virus treatments. The trend shows a growing interest in its analogs due to their enhanced stability and efficacy. Price trends are influenced by supply chain disruptions and demand fluctuations in pharmaceutical markets.

How should waste containing N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) be handled?

Waste containing N-Carbobenzyloxy-L-valinyl-ganciclovir (CAS: 194154-40-0) should be collected in a sealed container and stored in a cool, dry location away from direct sunlight. It should be disposed of through professional waste disposal services that comply with local hazardous waste regulations. Environmental protection measures include proper labeling and documentation of waste handling procedures.